Cite

HARVARD Citation

    Singh, M. et al. (n.d.). Novel therapies in chronic lymphocytic leukaemia (CLL): quantifying the impact on patient relevant outcome measures. European journal of cancer. pp. S99-S100. [Online]. 
  
Back to record